Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2012 | 03-2012 | |
| Sales | 22,891 | 9,572 |
| Gross Profit | 22,891 | 9,572 |
| Operating Income | 22,891 | 9,572 |
| Pre-tax Income | 22,891 | 9,572 |
| Net Income Continuous | 12,467 | -2,619 |
| Net Income | $12,467 | $-2,619 |
| EPS Basic Total Ops | 1.12 | -0.25 |
| EPS Basic Continuous Ops | 1.12 | -0.25 |
| EPS Diluted Total Ops | 1.08 | -0.25 |
| EPS Diluted Continuous Ops | 1.08 | -0.25 |
| EBITDA(a) | $22,891 | $9,572 |